RT Journal Article
SR Electronic
T1 Prevalence and determinants of serum antibodies to SARS-CoV-2 in the general population of the Gardena Valley
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.03.19.21253883
DO 10.1101/2021.03.19.21253883
A1 Melotti, Roberto
A1 Scaggiante, Federica
A1 Falciani, Michela
A1 Weichenberger, Christian X.
A1 Foco, Luisa
A1 Lombardo, Stefano
A1 Grandi, Alessandro De
A1 Laer, Dorothee von
A1 Mahlknecht, Angelika
A1 Pramstaller, Peter P.
A1 Pagani, Elisabetta
A1 Meier, Horand
A1 Gaertner, Timon
A1 Troi, Christina
A1 Mascalzoni, Deborah
A1 Pattaro, Cristian
A1 Mian, Michael
YR 2021
UL http://medrxiv.org/content/early/2021/03/20/2021.03.19.21253883.abstract
AB Background Community-based studies are essential to quantify the spread of SARS-CoV-2 infection and for unbiased characterization of its determinants and outcomes. We conducted a cross-sectional study in the Gardena valley, a major Alpine touristic destination which was struck in the expansion phase of the COVID-19 pandemic over the winter 2020.Methods We surveyed 2244 representative study participants who underwent swab and serum antibody tests. We made multiple comparisons among the Abbott and Diasorin bioassays and serum neutralization titers. Seroprevalence accounted for the stratified design, non-response and test accuracy. Determinants and symptoms predictive of infection were analyzed by weighted multiple logistic regression.Results SARS-CoV-2 seroprevalence was 26.9% (95% confidence interval: 25.2%, 28.6%) by June 2020. The serum antibody bioassays had modest agreement with each other. Receiver operating characteristic curve analysis on the serum neutralizing capacity showed better performance of the Abbott test at lower than the canonical threshold. Socio-demographic characteristics showed no clear evidence of association with seropositivity, which was instead associated with place of residence and economic activity. Loss of taste or smell, fever, difficulty in breathing, pain in the limbs, and weakness were the most predictive symptoms of positive antibody test results. Fever and weakness associations were age-dependent.Conclusion The Gardena valley had one of the highest SARS-CoV-2 infection prevalence in Europe. The age-dependent risk associated with COVID-19 related symptoms implies targeted strategies for screening and prophylaxis planning.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Healthcare System of the Autonomous Province of Bolzano/BozenAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Ethics Committee of the Healthcare System of the Autonomous Province of Bolzano/Bozen authorized the study.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAny request to access the data should be forwarded to the corresponding authors.